Beacon Pharmaceuticals Ltd------- Prospectus
Beacon Pharmaceuticals Ltd------- Prospectus
Beacon Pharmaceuticals Ltd------- Prospectus
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Light for Life<br />
BEACON<br />
Lien status<br />
The tangible assets of the company are mortgaged to the lending banks' against project finance and C.C (Hypo) loan<br />
namely;<br />
1. Janata Bank Limited<br />
2. Agrani Bank Limited<br />
3. Sonali Bank Limited<br />
4. Social Investment bank Limited<br />
5. The City bank Limited<br />
6. Shahjalal Islami bank Limited<br />
7. Dhaka Bank Limited<br />
8. Southeast Bank Limited<br />
9. ICB Islami Bank Limited &<br />
10. First Security Bank Limited.<br />
Leased Property<br />
The Company doesn't have any leased property.<br />
PLAN OF OPERATION AND DISCUSSION OF FINANCIAL CONDITION<br />
Internal and external sources of cash<br />
1. Internal Sources:<br />
(Amount in Taka)<br />
01.07.08 01.07.07 01.07.06<br />
01.07.05<br />
Particulars<br />
to<br />
to<br />
to<br />
to<br />
30.06.09 30.06.08 30.06.07<br />
30.06.06<br />
Paid-up Capital 600,000,000 600,000,000 600,000,000 600,000,000<br />
Revaluation Reserve 401,943,872 - - -<br />
Retained Earnings for 18,325,735 (17,182,320) (40,497,082) -<br />
the year<br />
Retained Earnings<br />
(39,205,969) (57,679,402) (40,497,082)<br />
(Cumulative)<br />
Total 962,737,903 542,320,598 559,502,918 600,000,000<br />
External Sources:<br />
(Amount in Taka)<br />
Particulars<br />
01.07.08<br />
to<br />
30.06.09<br />
01.07.07<br />
to<br />
30.06.08<br />
01.07.06<br />
to<br />
30.06.07<br />
01.07.05<br />
to<br />
30.06.06<br />
Long Term Loan 1,424,148,921 1,194,489,473 945,047,923 756,954,088<br />
Short Term Loan 567,076,684 391,282,929 306,452,245 174,743,846<br />
Total 1,991,225,605 1,585,772,402 1,251,500,168 931,697,934<br />
2. Material Commitments for Capital Expenditure:<br />
The company has not made any material commitment for capital expenditure.<br />
17<br />
PROSPECTUS